[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0776195T3 - Lægemiddelafgivelsespræparat indeholdende chitosan eller derivater deraf med defineret Z-potentiale - Google Patents

Lægemiddelafgivelsespræparat indeholdende chitosan eller derivater deraf med defineret Z-potentiale

Info

Publication number
DK0776195T3
DK0776195T3 DK95929164T DK95929164T DK0776195T3 DK 0776195 T3 DK0776195 T3 DK 0776195T3 DK 95929164 T DK95929164 T DK 95929164T DK 95929164 T DK95929164 T DK 95929164T DK 0776195 T3 DK0776195 T3 DK 0776195T3
Authority
DK
Denmark
Prior art keywords
pct
particles
chitosan
potential
derivatives
Prior art date
Application number
DK95929164T
Other languages
Danish (da)
English (en)
Inventor
Lisbeth Illum
Peter James Watts
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Application granted granted Critical
Publication of DK0776195T3 publication Critical patent/DK0776195T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK95929164T 1994-08-20 1995-08-21 Lægemiddelafgivelsespræparat indeholdende chitosan eller derivater deraf med defineret Z-potentiale DK0776195T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416884A GB9416884D0 (en) 1994-08-20 1994-08-20 Drug delivery compositions
PCT/GB1995/001980 WO1996005810A1 (en) 1994-08-20 1995-08-21 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential

Publications (1)

Publication Number Publication Date
DK0776195T3 true DK0776195T3 (da) 2001-12-27

Family

ID=10760170

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95929164T DK0776195T3 (da) 1994-08-20 1995-08-21 Lægemiddelafgivelsespræparat indeholdende chitosan eller derivater deraf med defineret Z-potentiale

Country Status (13)

Country Link
US (1) US5840341A (de)
EP (1) EP0776195B1 (de)
JP (1) JPH10508004A (de)
AT (1) ATE208193T1 (de)
AU (1) AU688566B2 (de)
DE (1) DE69523765T2 (de)
DK (1) DK0776195T3 (de)
ES (1) ES2167453T3 (de)
FI (1) FI970694A (de)
GB (2) GB9416884D0 (de)
NO (1) NO315636B1 (de)
PT (1) PT776195E (de)
WO (1) WO1996005810A1 (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
EP0994726B1 (de) * 1996-07-10 2002-04-17 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Zusammensetzungen zur einführung von genen in epithelzellen
US6649192B2 (en) 1996-07-29 2003-11-18 Universidade De Santiago De Compostela Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
DE19712978A1 (de) * 1997-03-27 1998-10-01 Henkel Kgaa Chitosanmikrosphären
DE69841984D1 (de) * 1997-09-05 2010-12-16 Maruho K K Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DE19756314C2 (de) * 1997-12-12 2000-06-29 Roland Bodmeier Zubereitung mit verlängerter Verweildauer am Applikationsort
JPH11246392A (ja) * 1998-03-03 1999-09-14 Makoto Otsuka 経口用固形製剤
KR100306221B1 (ko) * 1998-12-17 2002-03-21 김충섭 서방성키토산미세캡슐의제조방법
GB9905136D0 (en) 1999-03-06 1999-04-28 Danbiosyst Uk Surface modification of lamellar particles
DK1196430T3 (da) 1999-06-29 2012-05-21 Mannkind Corp Rensning og stabilisering af peptider og proteiner i farmaceutiske midler
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ATE239469T1 (de) * 1999-10-01 2003-05-15 Degussa Alpha-liponsäure(-derivate)enthaltende retardform
GB9924797D0 (en) * 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
AU6627201A (en) * 2000-05-03 2001-11-12 Mbt Munich Biotechnology Gmbh Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
US20030134810A1 (en) * 2001-10-09 2003-07-17 Chris Springate Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
US20030224000A1 (en) * 2001-12-21 2003-12-04 Kokai-Kun John Fitzgerald Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
US20040266026A1 (en) * 2002-01-10 2004-12-30 Amiji Mansoor M. Hybrid immobilized catalytic system with controlled permeability
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
US20080214437A1 (en) * 2002-09-06 2008-09-04 Mohapatra Shyam S Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
US7655772B2 (en) 2002-09-06 2010-02-02 University Of South Florida Materials and methods for treatment of allergic diseases
US20060110359A1 (en) * 2002-09-06 2006-05-25 Juan Sanchez-Ramos Cellular delivery of natriuretic peptides
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition
CA2524286A1 (en) * 2003-05-01 2004-11-18 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Li Mited Nasal administration of the lh-rh analog leuprolide
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US20050147581A1 (en) * 2003-11-19 2005-07-07 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes having improved stability and therapeutic use of the same
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
WO2005094420A2 (en) * 2004-02-17 2005-10-13 University Of South Florida Materials and methods for treatment of inflammatory and cell proliferation disorders
EP1742612A2 (de) * 2004-05-06 2007-01-17 Ivrea Pharmaceuticals, Inc. Partikel zur wirkstofffreisetzung
WO2006023849A2 (en) 2004-08-20 2006-03-02 Mannkind Corporation Catalysis of diketopiperazine synthesis
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
US7892414B1 (en) 2004-11-19 2011-02-22 The United States Of America As Represented By The Secretary Of Army Electrochemical biosensors, applications and methods of making biosensors
ES2277743B2 (es) 2005-06-02 2008-12-16 Universidade De Santiago De Compostela Nanoparticulas que comprenden quitosano y ciclodextrina.
CA2621806C (en) 2005-09-14 2016-08-02 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
WO2007098500A2 (en) 2006-02-22 2007-08-30 Mannkind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
AU2007285472B2 (en) * 2006-03-30 2013-10-24 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
CA2656990A1 (en) * 2006-04-28 2007-11-08 University Of South Florida Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor
PL2028937T5 (pl) * 2006-05-22 2018-12-31 Vanda Pharmaceuticals Inc. Leczenie za pomocą agonisty melatoniny
CN101148511B (zh) * 2006-09-18 2010-10-20 中国科学院过程工程研究所 荧光壳聚糖微球的制备方法及其在示踪剂领域的应用
WO2008091592A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
KR101610268B1 (ko) 2007-08-28 2016-04-07 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 외과용 하이드로겔
GB0716907D0 (en) 2007-08-31 2007-10-10 Archimedes Dev Ltd Pharmaceutical powder compositions
EP2057982A1 (de) 2007-11-09 2009-05-13 Archimedes Development Limited Intranasale Zusammensetzungen
EP2291524A2 (de) 2008-04-24 2011-03-09 Medtronic, Inc Rehydratisierbare thiolierte polysaccharidpartikel und schwamm
WO2009132227A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Protective gel based on chitosan and oxidized polysaccharide
US8530632B2 (en) 2008-04-24 2013-09-10 Medtronic Xomed, Inc. Chitosan-containing protective composition
CN105664197A (zh) 2008-04-24 2016-06-15 麦德托尼克公司 冷电离辐射灭菌
EP2123261A1 (de) * 2008-05-20 2009-11-25 Stallergenes S.A. Speichelklebende Partikelformulierung zur Induzierung von antigenspezifischer Immuntoleranz
AU2009257311B2 (en) 2008-06-13 2014-12-04 Mannkind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MX2010014240A (es) 2008-06-20 2011-03-25 Mankind Corp Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
JP2009149675A (ja) * 2009-02-24 2009-07-09 Novadel Pharma Inc 極性または非極性の、バッカルスプレーまたはカプセル
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
EP2496295A1 (de) 2009-11-03 2012-09-12 MannKind Corporation Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
JP6385673B2 (ja) 2010-06-21 2018-09-05 マンカインド コーポレイション 乾燥粉末薬物送達システム
US10184942B2 (en) 2011-03-17 2019-01-22 University Of South Florida Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
RU2569776C2 (ru) 2011-04-01 2015-11-27 Маннкайнд Корпорейшн Блистерная упаковка для фармацевтических картриджей
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR102317399B1 (ko) 2012-01-26 2021-10-26 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
EP2872205B1 (de) 2012-07-12 2017-02-08 MannKind Corporation System zur verabreichung von arzneimitteln in trockenpulverform
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
EP2934509B1 (de) 2012-12-18 2020-05-27 Vanda Pharmaceuticals Inc. Tasimelteon zur behandlung von störungen des circadianen rhythmus
SG11201507564PA (en) 2013-03-15 2015-10-29 Mannkind Corp Microcrystalline diketopiperazine compositions and methods
AU2014242658A1 (en) * 2013-03-26 2015-11-12 Optinose As Nasal administration
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
MX2020009878A (es) 2013-07-18 2022-07-27 Mannkind Corp Composiciones farmaceuticas en polvo seco estables al calor y metodos.
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
JP6945614B2 (ja) * 2014-03-26 2021-10-06 オプティノーズ アズ 経鼻投与
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
RU2016152090A (ru) * 2014-06-25 2018-07-27 Оптиноуз Ас Интраназальное введение
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JOP20180128A1 (ar) * 2018-12-24 2020-06-24 Univ Of Petra صيغة دوائية صلبة قابلة للتشتت في الفم

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895724A (en) * 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
US5129877A (en) * 1988-04-29 1992-07-14 University Of Georgia Research Foundation, Inc. Receptor-mediated delivery system
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration

Also Published As

Publication number Publication date
EP0776195A1 (de) 1997-06-04
FI970694A0 (fi) 1997-02-19
DE69523765D1 (de) 2001-12-13
DE69523765T2 (de) 2002-09-26
GB9702503D0 (en) 1997-03-26
FI970694A (fi) 1997-02-19
ATE208193T1 (de) 2001-11-15
US5840341A (en) 1998-11-24
NO970507D0 (no) 1997-02-05
GB2305124A (en) 1997-04-02
ES2167453T3 (es) 2002-05-16
EP0776195B1 (de) 2001-11-07
PT776195E (pt) 2002-04-29
NO970507L (no) 1997-02-05
GB9416884D0 (en) 1994-10-12
AU3262695A (en) 1996-03-14
NO315636B1 (no) 2003-10-06
AU688566B2 (en) 1998-03-12
GB2305124B (en) 1998-11-18
JPH10508004A (ja) 1998-08-04
WO1996005810A1 (en) 1996-02-29

Similar Documents

Publication Publication Date Title
DK0776195T3 (da) Lægemiddelafgivelsespræparat indeholdende chitosan eller derivater deraf med defineret Z-potentiale
DE69105106D1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
AU678858B2 (en) Controlled release potassium dosage form
IE871526L (en) Dihydrocodeine composition
YU35893A (sh) Formulacije oksidona sa kontrolisanim otpuštanjem i njihova upotreba
ATE157867T1 (de) Geschmacksmaskierende zusammensetzungen von ranitidin
CA2439570A1 (en) In-situ gel formation of pectins
RU2004124837A (ru) Содержащая кальций жевательная резинка с начинкой-наполнителем
CA2341568A1 (en) Stabilized pharmaceutical composition in lyophilized form
GB9718568D0 (en) Compositions
CA2197062A1 (en) Drug delivery composition containing chitosan or derivative thereof having a defined z. potential
JP3240593B2 (ja) 可溶性コラーゲンパウダーを担体とする医薬徐放剤
KR860000070A (ko) 종양 발육억제 조성물
KR0171413B1 (ko) 젬피브로질 제제
US5281421A (en) Gemfibrozil formulations
US4978533A (en) Liquid nifidipine composition
JPH05339141A (ja) 肌荒れ防止剤
JPH0511093B2 (de)
YU20050413A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem
YU20050410A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem
TH7624A (th) การเตรียมส่วนประกอบสำหรับช่องปาก
TH7624EX (th) การเตรียมส่วนประกอบสำหรับช่องปาก
MY124416A (en) Pharmaceutical composition for application to mucosa